Beijing Enterprises Medical and Health Industry : DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE DISCLOSEABLE AND CONNECTED TRANSACTION

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaims any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2389)

DELAY IN DESPATCH OF CIRCULAR IN RELATION TO THE DISCLOSEABLE AND CONNECTED TRANSACTION

References are made to the announcements of the Company dated 9 July 2020 and 16 July 2020 in relation to the acquisition by way of loan capitalisation (the "Announcements"). Unless context requires otherwise, capitalised terms used herein shall have the same meanings as those defined in the Announcements.

As disclosed in the Announcements, a circular (the "Circular") containing, among other things, (i) details of the Listco Loan Capitalisation Agreement and the transactions contemplated thereunder; (ii) a letter of recommendation from the Independent Board Committee to the Independent Shareholders and a letter of advice from the independent financial adviser to the Independent Board Committee and the Independent Shareholders in relation to the Listco Loan Capitalisation Agreement and the transactions contemplated thereunder; and (iii) a notice convening the EGM, is expected to be despatched to the Shareholders on or before 31 July 2020.

As additional time is required to prepare and finalise the information to be included in the Circular, the Company would like to extend the time for the despatch of the Circular to a date on or before 7 August 2020.

By order of the Board

Beijing Enterprises Medical and Health

Industry Group Limited

Zhu Shi Xing

Chairman

Hong Kong, 31 July 2020

As at the date of this announcement, the Board comprises seven executive directors, namely Mr. Zhu Shi Xing, Mr. Liu Xue Heng, Mr. Gu Shan Chao, Mr. Siu Kin Wai, Mr. Hu Shiang Chi, Mr. Wang Zheng Chun and Mr. Zhang Jing Ming and five independent non-executive directors, namely Mr. Robert Winslow Koepp, Mr. Gary Zhao, Mr. Tse Man Kit, Keith, Mr. Wu Yong Xin and Mr. Zhang Yun Zhou.